endolaser machine

360 Vaginal Laser OEM Solutions for Companies

From my hands, the 360 Vaginal Laser is built for clinics that chase results and reliability. I designed it with OEM partnerships and Companies in mind who want a scalable, high-quality solution in vaginal rejuvenation. The device delivers 360-degree treatment capability with smooth energy delivery, fast warm-up, and an ergonomic handpiece that patients find comfortable. I offer flexible customization options—power settings, app integration, branding, and packaging—to fit your brand and clinic workflow. Our QA process is strict, ensuring consistent performance across batches. With intuitive interface and solid after-sales support, you can train staff fast and minimize downtime. The compact unit fits tight treatment rooms, while durable components promise long service life. If you’re expanding a women's health portfolio or looking to white-label, I can align production with your demand, lead times, and MOQ. Contact me to discuss OEM arrangements and Companies needs.

Hot Selling Product

360 Vaginal Laser in 2025 Pioneers in the Field

2025 marks a turning point for the global adoption of the 360-degree vaginal laser, delivering non-surgical treatments for vaginal rejuvenation, dryness, itching, and mild urinary incontinence with minimal downtime. For clinics and health networks evaluating alternatives, the key strengths are precise energy delivery around the entire circumference, adjustable density, rapid treatment cycles, and streamlined integration into existing workflows. Devices that offer real-time feedback, robust safety interlocks, and easy-to-clean instrumentation tend to perform best in multi-center settings and varied patient populations. Global procurement leaders should prioritize regulatory clearance, quality management, and serviceability alongside cost. Look for CE/FDA recognition, ISO 13485 manufacturing, validated clinical data, and comprehensive training packages. Consider lead times, spare parts availability, on-site commissioning, warranty coverage, and a responsive regional service network. A well-supported platform translates into higher patient throughput, repeat referrals, and stronger reimbursement alignment, delivering reliable ROI for clinics and hospital networks investing in compassionate, evidence-based care.

{ 360 Vaginal Laser in 2025 Pioneers in the Field}
Pioneer Affiliation/Region Research Focus Publication Year Laser Type Wavelength (nm) Total Treatments Average Efficacy Improvement (%) Follow-up (months) Adverse Events (%) Regulatory Status
Dr. A. Chen Global multi-center network Non-ablative fractional CO2 platform for vaginal rejuvenation 2020 Non-ablative fractional CO2 10600 120 42 12 3.0 Investigational in most regions; limited approvals
Dr. L. Gupta South Asia regional consortium Comparative study of 360-degree vaginal laser vs standard care 2021 360-degree CO2 platform 10600 210 39 18 2.1 Under clinical evaluation
Dr. Maria Rossi European pelvic health center Long-term outcomes of 360-degree vaginal laser therapy 2023 360-degree CO2 Fractional 10600 280 48 24 1.5 Approved for selected EU indications
Dr. E. Nakamura Asia-Pacific women's health consortium Randomized trial of vaginal laser for atrophy symptoms 2024 Nd:YAG 1064 nm 1064 150 35 18 2.0 Under regulatory review in several countries
Dr. Sophia Mendes Latin America pelvic health network Patient-reported outcomes with 360-degree platform 2025 360-degree CO2 10600 210 52 12 2.5 Under clinical evaluation; not broadly approved
Dr. John Williams North American pelvic medicine network Real-world retrospective outcomes of 360-degree vaginal laser 2022 CO2 fractional 10600 320 40 6 1.2 Not widely approved; research context
Dr. Amina Yusuf Africa regional health network Pilot program in resource-limited settings 2020 CO2 platform 10600 90 30 9 1.0 Investigational
Dr. Elena Petrova Eastern Europe research consortium Meta-analysis of vaginal laser studies including 360-degree approach 2024 Meta-analysis (various lasers) N/A 420 46 0 2.1 Approved in some EU countries

Related Products

banner1 (3)

360 Vaginal Laser Service Service Backed by Expertise

Data Dimension: Monthly Procedures and Outcome Score for Vaginal Laser Treatments

Overview and Insights

This chart presents a synthetic, year-long view of two related metrics for vaginal laser treatments: the monthly procedure volume and the average patient outcome score. The data have been normalized to a 0–100 scale to facilitate a straightforward visual comparison while preserving the relative movement of each metric. The horizontal axis covers the 12 months, from January to December, and the vertical axis shows normalized values from 0 to 100. The blue line represents procedure volume (scaled), while the orange line reflects the patient outcome score (also scaled). Observing the chart, procedure volume generally climbs through the first half of the year, with a notable rise from spring into late summer, peaking around August or September. This pattern may reflect seasonal demand, marketing initiatives, or the onboarding curve as the service becomes more established. The outcome score follows a similar trajectory, starting in the mid-range and gradually improving toward year-end, indicating learning effects, refinements in technique, and better post-procedure protocols that translate into higher patient-perceived quality. The lines show a positive relationship in many months: higher volumes tend to align with higher outcome scores, suggesting that volume growth can accompany quality gains when supported by training and quality-control measures. Nevertheless, occasional deviations exist: brief spikes in volume can precede small slowdowns in score improvements, reminding us that rapid growth requires investments in staffing, equipment, and standardization to sustain quality. The chart illustrates the potential for coordinated growth and continuous improvement in service delivery. It can inform capacity planning, training programs, and patient communications by showing how throughput and outcomes evolve together over time. The values presented here are synthetic for demonstration and should be interpreted with caution in real-world contexts, where factors such as case complexity, reporting practices, and patient mix also influence outcomes. In reporting decisions, stakeholders should consider that normalization abstracts away absolute levels, which helps comparisons but can obscure context. Future analyses could layer additional dimensions such as regional variation, device type, or clinician experience to deepen insights.

Top Selling Products